Afghanistan vs Timor-Leste: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Afghanistan
- Timor-Leste
How they compare
Afghanistan currently reports 123.58 deaths against 93.18 deaths in Timor-Leste, a difference of 30.4 deaths.
That makes Afghanistan's figure about 1.3 times Timor-Leste's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Timor-Leste ahead.
Afghanistan ranks 123rd and Timor-Leste ranks 126th of 157 countries.
Across the 4 decades both report, Afghanistan averaged higher in 2 and Timor-Leste in 1.
Head to head by decade
| Decade | Afghanistan | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 0.4161 deaths | 1.78 deaths | 1.37 deaths | Timor-Leste |
| 2010s | 58.68 deaths | 23.13 deaths | 35.55 deaths | Afghanistan |
| 2020s | 108.95 deaths | 74.8 deaths | 34.15 deaths | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Afghanistan or Timor-Leste?
- Afghanistan, at 123.58 deaths against 93.18 deaths in Timor-Leste as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Afghanistan and Timor-Leste?
- 30.4 deaths, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Timor-Leste?
- 35 years are reported by both, from 1990 to 2024.
- How do Afghanistan and Timor-Leste rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Afghanistan ranks 123rd and Timor-Leste ranks 126th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.